Overcoming obstacles to AI-ready healthcare data
If artificial intelligence (AI) is going to remain the top news story for 2023, it has to continue...
If artificial intelligence (AI) is going to remain the top news story for 2023, it has to continue...
Patient tokenization replaces personal identifiers with encrypted tokens to link healthcare records...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Today’s most innovative companies are leveraging digital health data solutions to deliver...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
Few areas of medicine have captured public interest over the past two years quite like glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and...